Quark Venture LP
Quark Venture LP, established in 2016 and headquartered in Vancouver, Canada, is a venture capital firm focused on equity financing of innovative biotechnology and health sciences companies. The firm targets companies with breakthrough technology platforms and projects, aiming to support advancements in the biotechnology and health sciences sectors.
Portfolio
Microbion is developing pravibismane, a new class of anti-infective drugs targeting antibiotic-resistant infections. The company has received funding from CARB-X and the Cystic Fibrosis Foundation.
#Biopharmaceutical
ARTMS is developing the QUANTM Irradiation System for decentralized production of medical isotopes like Tc-99m, Ga-68, Cu-64, and Zr-89, aiming to stabilize global supply chains.
#Medical Isotopes
Alpha-9 is developing targeted radiopharmaceuticals for cancer treatment, with plans to advance five candidates into clinical trials and expand its research facilities.
#Radiopharmaceuticals
CalciMedica is focused on CRAC channel inhibitors for treating inflammatory diseases, including COVID-19 pneumonia and acute pancreatitis.
#Biotechnology
Key People
Chairman
Director, Business Development
Team Member